ESPERITE N.V (ESP) nominates Accon AVM as Auditor

November 27, 2017 Group News

Esperite N.V. (ESP) nominates Accon AVM as Auditor.

Amsterdam, the Netherlands – 27 November 2017

PDF Downloads

Esperite is pleased to announce that it has nominated Accon AVM as external auditor for the financial statements 2017.


ESPERITE is a diversified biotech global group leader in regenerative and precision medicine. Established in 2000, the holding group is headquartered in the Netherlands, listed at Euronext Amsterdam and Paris and operational in over 30 countries.

ESPERITE transforms the power of state-of-the-art technologies and scientific advancements into high quality products that bring the future of medicine to customers today at an affordable price.

To learn more about the ESPERITE group, or to book an interview with CEO Frederic Amar: +31 575 548 998 – or visit the websites at and

Related Articles